ハイブリッド手術室の世界市場:インサイト、機会分析、市場シェア、予測

◆英語タイトル:Global Hybrid Operating Rooms Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
◆商品コード:OCCAM60569
◆発行会社(調査会社):Occams Research
◆発行日:2016年2月30日
◆ページ数:212
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,900 ⇒換算¥786,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

The healthcare industry is gradually transforming from conventional operating methods to intraoperative approach for surgeries. An estimated 234 million major surgeries are performed every year globally which include cardiac catheterizations, endoscopy, neurosurgery and so on. The increasing demand for minimally invasive surgeries is driving growth of hybrid operating rooms. The growing demand for minimally invasive surgeries and various technological innovations in the healthcare industry are the major driving force for the global healthcare industry. However, high cost of establishment and safety concerns are still major challenges before the market. The market is dominated by applications in cardiovascular and neurosurgery both contributing to more than 60% of the market share.
Key companies profiled include
1. Maquet Getinge Group
2. Cook Medical
3. GE Healthcare
4. Karl Storz GmbH & Co. KG
5. Eschmann Equipment
6. Mizuho OSI
7. TRUMPF GmbH + Co. KG
8. Stryker Corporation
9. Skytron, LLC
10. NDS Surgical Imaging, LLC
11. STERIS Corporation
12. Philips Healthcare
13. Siemens Healthcare
14. Toshiba Healthcare
15. Barco
16. Johnson and Johnson
17. SISCO Ltd
18. Sontec Instruments
19. Mediflex
20. Sklar

This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies

【レポートの目次】

Chap 1. Executive Summary
1.1. Methodology
Chap 2. Market Overview
2.1. Definition
2.2. Key Findings
2.2.1. Market Opportunities are in Asia Pacific
2.2.2. Cardiovascular & Neurosurgery Dominates the Therapeutic Application Market
2.2.3. Demand For Non Invasive Surgeries Is Driving The Market Growth
2.2.4. Surgical Imaging Display Market Promising Great Future
2.2.5. Imaging Systems Will Have The Highest Market Share Driven By Presence Of Major Diagnostic Imaging Companies
2.2.6. Partnerships And Collaborations Are The Winning Strategies For The Market Players
2.3. Key Buying Criteria
2.3.1. Patient Care & Safety
2.3.2. Price
2.3.3. Success Rates
2.3.4. Operating Room Design
2.4. Value Chain Analysis
2.5. Planning And Establishment Of Hybrid Operating Room
2.5.1. Planning
2.5.2. Design And Construction
2.5.3. Location
2.5.4. Imaging Devices
2.5.4.1. Mobile & Fixed Systems
2.5.4.2. Image Intensifier And Flat Panel Detector System
2.5.4.3. Ceiling And Floor Mounted Systems
Chap 3. Market Determinants
3.1. Drivers Of Hybrid Operating Rooms
3.1.1. Healthcare Reforms Advancements In Healthcare Technologies Drive Product Innovation
3.1.2. Benefits Over Conventional Operating Systems Drive Adoption
3.1.2.1. Hybrid Or Provides Maximum Flexibility
3.1.2.2. Clinical Decision Support Systems
3.1.3. Increasing Number Of Ascs (Ambulatory Surgical Centers)
3.1.4. Decreasing Mortality And Morbidity Demands For A Safer Operating Environment
3.1.5. Growing Number Of Heart Patients Globally
3.1.6. Hybrid Approach To Minimally Invasive Heart Surgery
3.1.7. Smart Healthcare Will Drive Faster Adoption
3.1.8. Global Increase In Healthcare Spending
3.1.9. Increasing Number Of Surgeries
3.2. Restraints Of Global Hybrid Operating Rooms Market
3.2.1. High Cost Of Operating Room Equipment
3.3. Market Opportunities
3.3.1. Emerging Economies In Asia-Pacific And Latin America
3.3.2. Technology Is The Key To Success
3.3.2.1. Surgical Therapeutics
3.3.2.2. Robotics
Chap 4. Market Segmentation By Applications
4.1. Therapeutic
4.1.1. Cardiovascular OR
4.1.1.1. Globally CVD Burdens Almost All The Region
4.1.1.2. Research And Development In CVD Therapeutics
4.1.2. Neurosurgery
4.1.2.1. Some Brands Of Neurological Monitors
4.1.3. Thoracic Surgery
4.1.4. Biopsy
4.1.5. Orthopedic Surgeries
4.1.6. Laparoscopic Surgeries
4.1.7. Emergency Care
4.1.8. Other Surgeries
4.2. Diagnostic Imaging
4.2.1. Fluoroscopy
4.2.2. Digital Subtraction Angiography
4.2.3. Three-Dimensional (3d) C-Arm Computed Tomography
Chap 5. Market Segmentation By Device
5.1. Operating Tables
5.1.1. Mobile Operating Tables
5.1.2. Stationary Operating Tables
5.2. Operating Room Lights
5.2.1. Dimmable Lights
5.2.2. Led Lighting
5.2.3. Halogens
5.3. Surgical Booms
5.4. Surgical Imaging Displays
5.5. Intraoperative Diagnostic Devices
5.5.1. 3D Ultrasound
5.5.2. MRI (Magnetic Resonance Imaging)
5.5.2.1. Top Brands And Manufacturers Of MRI
5.5.3. Computer Tomography
5.5.4. Computer Assisted Robotic Surgery
5.5.5. C-Arm X-Ray
5.5.6. Infra Red Imaging Systems
5.6. Operating Room Communication Systems
5.6.1. Audio Visual
5.6.2. Operating Room Integration System
5.6.2.1. WiFi
5.6.2.2. RFID
5.6.2.3. PACS
Chap 6. Geographical Analysis
6.1. North America
6.1.1. United States (U.S.)
6.1.1.1. Prevalent Diseases In US
6.1.1.2. Diabetes In The US
6.1.1.3. The US Regulations (FDA)
6.1.2. Canada
6.1.2.1. Diseases Prevalent In Canada
6.1.2.1.1. Cardiovascular Diseases (CVD)
6.1.2.1.2. Cancer
6.1.2.1.3. Diabetes
6.1.2.2. Regulations In Canada
6.2. Europe
6.2.1. Regulations Regarding Medical Devices In Europe
6.2.2. Prevalent Diseases In Europe
6.2.3. United Kingdom (UK)
6.2.3.1. Diseases Prevalent In UK
6.2.4. France
6.2.5. Germany
6.2.5.1. Diseases Prevalent In Germany
6.2.6. Spain
6.2.7. Italy
6.3. Asia Pacific
6.3.1. India
6.3.1.1. Prevalence Of CVD And Other Heart Diseases In India
6.3.1.2. Regulations In India
6.3.1.3. Opportunities In India
6.3.2. China
6.3.2.1. Diseases Prevalent In China
6.3.2.1.1. CVD
6.3.2.1.2. Regulations In China
6.3.3. Japan
6.3.3.1. Diseases Prevalent In Japan
6.3.3.2. Regulations In Japan
6.3.4. Korea
6.3.4.1. Regulations In Korea
6.4. Rest Of The World
6.4.1. Latin America
6.4.1.1. Brazil
6.4.1.1.1. Prevalent Diseases In Brazil
6.4.1.1.2. Mexico
6.4.1.1.3. Regulations
6.4.1.1.4. Prevalence Of Diseases In Mexico
Chap 7. Competitive Landscape
7.1. Key Strategies
7.1.1. Partnerships
7.1.2. Acquisitions
7.1.3. Product Launch
Chap 8. Company Profiling
8.1. Barco Nv
8.1.1. Overview
8.1.2. Barco Nv Products Portfolio In Hybrid Or
8.1.3. Strategic Moves
8.1.4. SCOT Analysis
8.2. Cook Medical
8.2.1. Overview
8.2.2. Cook Medical Products Portfolio In Hybrid OR
8.2.3. SCOT Analysis
8.3. Eschmann Equipment
8.3.1. Overview
8.3.2. Eschmann Product Portfolio In Hybrid OR
8.3.3. SCOT Analysis
8.4. GE Healthcare
8.4.1. Overview
8.4.2. GE Healthcare Product Portfolio In Hybrid Or
8.4.3. Strategic Moves
8.4.4. SCOT Analysis
8.5. Johnson & Johnson
8.5.1. Overview
8.5.2. Johnson & Johnson Products Portfolio In Hybrid OR
8.5.3. SCOT Analysis
8.6. Karl Storz Gmbh & Co. KG
8.6.1. Overview
8.6.2. Karl Storz Product Portfolio In Hybrid OR
8.6.3. Strategic Moves
8.6.4. SCOT Analysis
8.7. Maquet Getinge Group
8.7.1. Overview
8.7.2. Maquet Product Portfolio In Hybrid OR
8.7.3. Strategic Moves
8.7.4. SCOT Analysis
8.8. Mediflex
8.8.1. Overview
8.8.2. Mediflex Product Portfolio In Hybrid OR
8.8.3. SCOT Analysis
8.9. Mizuho OSI
8.9.1. Overview
8.9.2. Mizuho OSI Product Portfolio In Hybrid OR
8.9.3. Strategic Moves
8.9.4. SCOT Analysis
8.10. NDS Surgical Imaging, LLC
8.10.1. Overview
8.10.2. NDS Surgical Imaging Product Portfolio In Hybrid OR
8.10.3. Strategic Moves
8.10.4. SCOT Analysis
8.11. Philips Healthcare
8.11.1. Overview
8.11.2. Phillips Healthcare Products Portfolio In Hybrid OR
8.11.3. Strategic Moves
8.11.4. SCOT Analysis
8.12. Siemens Healthcare GMBH
8.12.1. Overview
8.12.2. Siemens Healthcare Products Portfolio In Hybrid OR
8.12.3. Strategic Moves (2013-14)
8.12.4. SCOT Analysis
8.13. Sisco Ltd
8.13.1. Overview
8.13.2. Sisco Product Portfolio In Hybrid OR
8.13.3. SCOT Analysis
8.14. Sklar
8.14.1. Overview
8.14.2. Sklar Product Portfolio In Hybrid OR
8.14.3. SCOT Analysis
8.15. Skytron, LLC
8.15.1. Overview
8.15.2. Skytron Product Portfolio In Hybrid OR
8.15.3. Strategic Moves
8.15.4. SCOT Analysis
8.16. Sontec Instruments
8.16.1. Overview
8.16.2. Sontec Instruments Product Portfolio In Hybrid OR
8.16.3. Strategic Moves
8.16.4. SCOT Analysis
8.17. Steris Corporation
8.17.1. Overview
8.17.2. Steris Product Portfolio In Hybrid OR
8.17.3. SCOT Analysis
8.18. Stryker Corporation
8.18.1. Overview
8.18.2. Stryker Product Portfolio In Hybrid OR
8.18.3. Strategic Moves
8.18.4. SCOT Analysis
8.19. Toshiba Medical Systems
8.19.1. Overview
8.19.2. Toshiba Medical System Products Portfolio In Hybrid OR
8.19.3. Strategic Moves
8.19.4. SCOT Analysis
8.20. Trumpf Gmbh + Co. KG
8.20.1. Overview
8.20.2. Trumpf Product Portfolio In Hybrid OR
8.20.3. Strategic Moves
8.20.4. SCOT Analysis


TABLE 1 GLOBAL HYBRID OPERATING ROOMS MARKET BY THERAPEUTIC APPLICATIONS IN 2014-2022 ($ BILLION)
TABLE 4 COST OF DRUGS IN US
TABLE 5 PRICE DIFFERENCE IN INDIA AND US FOR CARDIAC RELATED SURGERIES
TABLE 6 GLOBAL HYBRID OR MARKET BY APPLICATIONS IN 2014-2022 ($ BILLION)
TABLE 7 GLOBAL THERAPEUTIC APPLICATIONS MARKET BY TYPE IN 2014-2022 ($ BILLION)
TABLE 8 GLOBAL THERAPEUTIC APPLICATIONS MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 9 GLOBAL CARDIOVASCULAR THERAPY MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 10 GLOBAL NEUROVASCULAR THERAPY MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 11 GLOBAL THORACIC SURGERY MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 12 GLOBAL BIOPSY MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 13 PRICELIST OF ORTHOPEDIC OUTPATIENT SERVICES AND DIAGNOSTICS IN EUROPE 2013
TABLE 14 GLOBAL ORTHOPEDIC SURGERIES MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 15 GLOBAL LAPAROSCOPIC SURGERIES MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 16 GLOBAL EMERGENCY CARE MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 17 GLOBAL EMERGENCY CARE MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 18 GLOBAL DIAGNOSTIC IMAGING MARKET BY TYPE 2014-2022 ($ BILLION)
TABLE 19 GLOBAL FLUOROSCOPY MARKET BY GEOGRAPHY 2014-2022 ($ BILLION)
TABLE 20 GLOBAL DIGITAL SUBTRACTION ANGIOGRAPHY MARKET BY GEOGRAPHY IN $BILLION (2015-2021)
TABLE 21 GLOBAL THREE-DIMENSIONAL (3D) C-ARM COMPUTED TOMOGRAPHY MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 22 PRICELIST OF DIFFERENT CT SCANS IN US
TABLE 23 GLOBAL HYBRID OPERATING TABLE MARKET BY TYPE IN 2014-2022 ($ BILLION)
TABLE 24 PROPERTIES REQUIRED IN AN OPERATING TABLE
TABLE 25 GLOBAL MOBILE OPERATING TABLE MARKET BY GEOGRAPHY 2014-2022 ($ BILLION)
TABLE 26 GLOBAL STATIONARY OPERATING TABLE MARKET BY GEOGRAPHY 2014-2022 ($ BILLION)
TABLE 27 GLOBAL STATIONARY OPERATING ROOM LIGHTS MARKET BY GEOGRAPHY IN $BILLION (2015-2021)
TABLE 28 VARIOUS CONSIDERATIONS FOR SELECTING LIGHTING SYSTEMS FOR OPERATING ROOM
TABLE 29 GLOBAL SURGICAL BOOMS MARKET BY GEOGRAPHY 2014-2022 ($ BILLION)
TABLE 30 GLOBAL SURGICAL IMAGE DISPLAYS MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 31 VARIOUS FACTORS TO BE CONSIDERED FOR SURGICAL DISPLAYS ARE
TABLE 32 GLOBAL INTRAOPERATIVE DIAGNOSTIC DEVICE MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 33 PRICES OF SOME OF THE BRANDED ULTRASOUND MACHINES
TABLE 34 COSTS OF VARIOUS BRANDED MRI MACHINES
TABLE 35 PRICELIST OF DIFFERENT CT SCANS IN US
TABLE 36 GLOBAL OPERATING ROOM COMMUNICATION SYSTEM MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 37 GLOBAL OPERATING ROOM COMMUNICATION SYSTEM MARKET BY TYPE IN 2014-2022 ($ BILLION)
TABLE 38 GLOBAL HYBRID OPERATING ROOM MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 39 NORTH AMERICA HYBRID OPERATING ROOM MARKET BY GEOGRAPHY IN 2014-2022 ($ BILLION)
TABLE 40 DIFFERENT PROCEDURES PERFORMED IN US IN 2014
TABLE 41 CANCER PERCENTAGE IN CANADA 2014
TABLE 42 EUROPE HYBRID OPERATING ROOM MARKET IN 2014-2022 ($ BILLION)
TABLE 43 FATALITY IN EUROPE IN 2012
TABLE 44 CVD STATISTICS OF THE UK IN 2014
TABLE 45 NUMBER OF CARDIOLOGISTS IN SPAIN IN 2013
TABLE 46 EUROPE HYBRID OPERATING ROOM MARKET IN 2014-2022 ($ BILLION)
TABLE 47 ROW HYBRID OR MARKET IN 2014-2022 ($ BILLION)



FIGURE 1 GLOBAL HYBRID OPERATING ROOM MARKET FORECAST BY REGION (2014-2022)
FIGURE 2 GLOBAL HYBRID OPERATING ROOMS MARKET (IN%) BY THERAPEUTIC APPLICATION IN 2013
FIGURE 3 C-ARMS MARKET GROWTH RATE (2014-2022)
FIGURE 4 KEY BUYING CRITERIA
FIGURE 5 STAKEHOLDERS IN THE HYBRID OPERATING ROOMS MARKET
FIGURE 6 PLANNING FOR A HYBRID OPERATING SYSTEM
FIGURE 7 MARKET DETERMINANTS OF GLOBAL HYBRID OPERATING ROOM MARKET
FIGURE 8 CONVENTIONAL VS HYBRID OPERATING ROOMS
FIGURE 10 PERCENTAGE DISTRIBUTION OF ASCS BY SPECIALITY
FIGURE 11 GLOBAL CORONARY HEART DISEASE MORTALITY RATES IN 2014
FIGURE 12 GLOBAL SMART HEALTHCARE MARKET 2014-2022 ($ BILLION)
FIGURE 13 COST STRUCTURE FOR HYBRID OPERATING ROOM INSTALLATION (%)
FIGURE 14 GLOBAL CARDIOVASCULAR THERAPY MARKET 2014-2022 ($ BILLION)
FIGURE 15 POPULATION AFFECTED IN LOW-MIDDLE INCOME COUNTRIES IN 2012
FIGURE 16 PERCENTAGE OF CVD IN 2012
FIGURE 17 GLOBAL NEUROSURGERY THERAPY MARKET 2014-2022 ($ BILLION)
FIGURE 18 GLOBAL THORACIC SURGERY MARKET 2014-2022 ($ BILLION)
FIGURE 19 GLOBAL BIOPSY MARKET 2014-2022 ($ BILLION)
FIGURE 20 ADVANTAGES AND RISK OF BIOPSY
FIGURE 21 GLOBAL ORTHOPEDIC SURGERIES MARKET 2014-2022 ($ BILLION)
FIGURE 22 GLOBAL LAPAROSCOPIC SURGERIES MARKET 2014-2022 ($ BILLION)
FIGURE 23 BENEFITS OF LAPAROSCOPIC SURGERY
FIGURE 24 GLOBAL FLUOROSCOPY MARKET BY 2014-2022 ($ BILLION)
FIGURE 25 ADVANTAGES OF FLUOROSCOPY
FIGURE 26 CT SCANS AND ITS BENEFITS
FIGURE 27 WIRELESS APPLICATIONS AND TECHNOLOGIES IN HOSPITAL SUPPORT
FIGURE 29 CVD PREVALENCE IN CANADA
FIGURE 30 FATALITIES DUE TO CVD IN 2014



【レポートのキーワード】

ハイブリッド手術室

★調査レポート[ハイブリッド手術室の世界市場:インサイト、機会分析、市場シェア、予測]販売に関する免責事項
★調査レポート[ハイブリッド手術室の世界市場:インサイト、機会分析、市場シェア、予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆